Gilmore O'Neill

Insider Reports History

Entity
Individual
Location
215 First Street, Cambridge, MA
Signature
/s/ Gilmore O'Neill
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gilmore O'Neill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Editas Medicine, Inc. CEO, Director Common Stock 314K $1.07M $3.42 Sep 4, 2024 Direct
Editas Medicine, Inc. CEO, Director Stock Option (right to buy) 392K Mar 2, 2024 Direct
Aptinyx Inc. Director Stock Option (Right to Buy) 40K May 26, 2022 Direct
Unity Biotechnology, Inc. Director Stock Option (Right to Buy) 10K Jun 21, 2024 Direct

Insider Reports Filed by Gilmore O'Neill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EDIT Editas Medicine, Inc. Sep 4, 2024 1 -$5.33K 4 Sep 6, 2024 CEO, Director
UBX Unity Biotechnology, Inc. Jun 21, 2024 1 $0 4 Jun 21, 2024 Director
EDIT Editas Medicine, Inc. Jun 4, 2024 1 -$67K 4 Jun 6, 2024 CEO, Director
EDIT Editas Medicine, Inc. Mar 2, 2024 5 -$733K 4 Mar 5, 2024 CEO, Director
UBX Unity Biotechnology, Inc. Jun 23, 2023 1 $0 4 Jun 26, 2023 Director
EDIT Editas Medicine, Inc. Jun 5, 2023 1 -$61.6K 4 Jun 7, 2023 CEO, Director
EDIT Editas Medicine, Inc. Mar 2, 2023 2 $0 4 Mar 6, 2023 CEO, Director
UBX Unity Biotechnology, Inc. Jun 24, 2022 1 $0 4 Jun 27, 2022 Director
EDIT Editas Medicine, Inc. Jun 2, 2022 2 $0 4 Jun 6, 2022 CEO, Director
EDIT Editas Medicine, Inc. Jun 1, 2022 0 $0 3 Jun 6, 2022 CEO, Director
APTX Aptinyx Inc. May 26, 2022 1 $0 4 May 31, 2022 Director
APTX Aptinyx Inc. Oct 19, 2021 1 $0 4 Oct 22, 2021 Director
APTX Aptinyx Inc. Oct 19, 2021 0 $0 3 Oct 22, 2021 Director
UBX Unity Biotechnology, Inc. Jun 24, 2021 1 $0 4 Jun 28, 2021 Director